NeuroSense Therapeutics L...

0.19
-0.01 (-4.52%)
At close: Apr 11, 2025, 3:59 PM
0.20
3.16%
After-hours: Apr 11, 2025, 04:00 PM EDT

NeuroSense Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
-11.28M -12.34M -4.04M -2.83M -1.22M
97K 89K 3K 3K n/a
1.54M 5.11M 4.16M 2.06M 611K
928K 291K 289K 37K 6K
1.3M -1.19M 791K -2K 591K
-2.01M n/a -2.72M 2K n/a
1.91M 750K 273K 69K 29K
-8.45M -7.59M -1.54M -695K -582K
-29K -70K -17K -9K -7K
3K n/a n/a n/a n/a
n/a -3.5M n/a n/a -19K
3.5M n/a n/a n/a n/a
-6K 29K n/a n/a -19K
3.47M -3.54M -17K -9K -26K
n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a
-75K 3.69M 2.04M n/a -3K
3.9M 3.69M 11.9M 508K 1.42M
-903K -7.52M 10.36M -196K 809K
-8.48M -7.66M -1.56M -704K -589K